What is the long-term safe treatment for prostate cancer?

Hi,

Welcome to icliniq.com.

I read your query and can understand your concern.

I want to start by saying that your concerns are completely valid and very common. A diagnosis of localized prostate cancer (cancer is confined to the prostate gland and has not spread to nearby tissues or other parts of the body) presents several treatment options, and choosing the right one involves balancing cure rates with quality of life, especially regarding urinary and sexual function.

Let us walk through your options.

First, what do we know about your cancer?

To provide the most tailored advice, it is important to know:

1. Your Gleason score (for example, 3 plus 3, 3 plus 4, 4 plus 3, etc.).

2. Your prostate-specific antigen level.

3. Magnetic resonance imaging findings, if done (any signs of extracapsular extension or high Prostate Imaging-Reporting and Data System score).

4. Number of positive biopsy cores and their extent.

5. Your general health and sexual health status.

Based on this, cancers generally fall into risk groups:

1. Low-risk: Gleason score 6, prostate-specific antigen less than 10 nanograms per milliliter, minimal involvement.

2. Favorable intermediate-risk: Gleason score 3 plus 4, prostate-specific antigen between 10 and 20 nanograms per milliliter.

3. Unfavorable intermediate or high-risk: Gleason score 4 plus 3 or higher, prostate-specific antigen greater than 20 nanograms per milliliter.

Your treatment options include:

Radical prostatectomy (surgical removal of the prostate):

Pros:

1. Removes the entire prostate gland with precise pathology analysis.

2. Allows for salvage radiation therapy if needed later.

3. Suited for healthy, younger men under 65 years seeking definitive treatment.

Cons:

1. Risk of urinary incontinence (5 to 15 percent) and erectile dysfunction (30 to 70 percent).

2. Nerve-sparing surgical techniques reduce risks but are not always possible depending on the disease stage.

Radiation therapy (external beam radiation or brachytherapy):

Pros:

1. Non-surgical, with less immediate impact on urinary continence

2. Provides equivalent long-term cancer control for most localized cancers

Cons:

1. Erectile dysfunction may develop gradually over months or years

2. Possible mild bowel or bladder irritation and fatigue during treatment

3. Salvage surgery after radiation therapy is more difficult

Active surveillance:

1. Ideal for low-risk cancers only.

2. Involves regular prostate-specific antigen testing, magnetic resonance imaging, and periodic biopsies.

3. Avoids or delays the side effects of treatment.

4. Not recommended for higher-risk cancers due to the risk of disease progression.

What is best for you?

At age 55 and still active, curative treatment is usually recommended for anything beyond low-risk disease. Specifically:

1. If you have a Gleason score 6, prostate-specific antigen less than 10, and low-volume disease, active surveillance can be a safe, low-disruption approach.

2. If you have a Gleason score 7 or higher, active surveillance is generally not advised, and surgery or radiation should be considered.

3. Both surgery and radiation can preserve quality of life, so it is important to consult with a urologic surgeon and a radiation oncologist before deciding.

Clinical trials you might consider:

Depending on your location and risk category, you may explore clinical trials involving:

1. Magnetic resonance imaging-guided focal therapies (such as high-intensity focused ultrasound or cryoablation, a treatment that destroys cancer cells by freezing them using extremely cold temperatures).

2. Genomic testing to guide surveillance or treatment decisions.

3. Shorter-course radiation therapy (hypofractionation).

4. Emerging trials for immune or hormonal therapies in borderline cases.

You can find trials through:

1. clinicaltrials.gov.

2. Your hospital’s uro-oncology unit.

3. Major academic centers like Memorial Sloan Kettering Cancer Center, Johns Hopkins Hospital, or MD Anderson Cancer Center.

You still have several good options, and at your age, you can benefit from definitive therapy if needed. Early detection means prostate cancer is very treatable, with long-term survival rates above 90 to 95 percent.

Share details from your biopsy (medical procedure where a small tissue sample is taken from the body to be examined under a microscope for signs of disease), magnetic resonance imaging, bone or positron emission tomography scan, and prostate-specific antigen levels. I can help guide you further.

You are doing the right thing by carefully considering your options, and asking these questions now means you are already ahead.

I hope this helps.

Please revert in case of further queries.

Thank you.